Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

December 30, 2015

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
RhinitisRhinoconjunctivitis
Interventions
BIOLOGICAL

MG56 Mannosylated 500 subcutaneous

Mixture of the following pollens: Phleum pratense, Dactylis glomerata, allergen extract with a concentration of 500 mTU (Mannosylated Therapeutic Units)/ml subcutaneous

BIOLOGICAL

MG56 Mannosylated 1000 subcutaneous

Mixture of the following pollens: Phleum pratense, Dactylis glomerata, allergen extract with a concentration of 1000 mTU (Mannosylated Therapeutic Units)/ml subcutaneous

BIOLOGICAL

MG56 Mannosylated 3000 subcutaneous

Mixture of the following pollens: Phleum pratense, Dactylis glomerata, allergen extract with a concentration of 3000 mTU (Mannosylated Therapeutic Units)/ml subcutaneous

BIOLOGICAL

MG56 Mannosylated 5000 subcutaneous

Mixture of the following pollens: Phleum pratense, Dactylis glomerata, allergen extract with a concentration of 5000 mTU (Mannosylated Therapeutic Units)/ml subcutaneous

BIOLOGICAL

MG56 Mannosylated 500 sublingual

Mixture of the following pollens: Phleum pratense, Dactylis glomerata, allergen extract with a concentration of 500 mTU (Mannosylated Therapeutic Units)/ml sublingual

BIOLOGICAL

MG56 Mannosylated 1000 sublingual

Mixture of the following pollens: Phleum pratense, Dactylis glomerata, allergen extract with a concentration of 1000 mTU (Mannosylated Therapeutic Units)/ml sublingual

BIOLOGICAL

MG56 Mannosylated 3000 sublingual

Mixture of the following pollens: Phleum pratense, Dactylis glomerata, allergen extract with a concentration of 3000 mTU (Mannosylated Therapeutic Units)/ml sublingual

BIOLOGICAL

MG56 Mannosylated 5000 sublingual

Mixture of the following pollens: Phleum pratense, Dactylis glomerata, allergen extract with a concentration of 5000 mTU (Mannosylated Therapeutic Units)/ml sublingual

BIOLOGICAL

Subcutaneous placebo

Comparison between placebo and active group

BIOLOGICAL

Sublingual placebo

Comparison between placebo and active group

Trial Locations (12)

28006

CLÍNICA Dr. SUBIZA, Madrid

Clínica Ojeda, Madrid

28034

Hospital Universitario Ramón y Cajal, Madrid

28041

HOSPITAL UNIVERSITARIO 12 de OCTUBRE, Madrid

28222

Hospital Universitario Puerta de Hierro, Majadahonda

28300

Clínica Atlas, Aranjuez

28342

Hospital Universitario Infanta Elena, Valdemoro

41009

Hospital Universitario Virgen Macarena, Seville

41013

Hospital Viamed Santa Angola de la Cruz, Seville

41703

Hospital San Agustín, Dos Hermanas

41950

Hospital Nisa Aljarafe, Castilleja de la Cuesta

47001

Clínica Alianza Médica, Valladolid

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Inmunotek S.L.

INDUSTRY

NCT02654223 - Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy | Biotech Hunter | Biotech Hunter